Chlorpheniramine

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Arrowhead Pharmaceuticals, Institute of Hematology & Blood Diseases Hospital, China

Conditions

Allergic ReactionsAllergic Transfusion ReactionHepatitis B, Chronic

Phase 1

Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents

CompletedNCT00837837

Wyeth is now a wholly owned subsidiary of PfizerAllergic Reactions

Start: 2008-12-21End: 2009-02-02Updated: 2020-10-23

Phase 2

A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

TerminatedNCT02065336

Arrowhead PharmaceuticalsHepatitis B, Chronic

Start: 2014-03-31End: 2017-01-31Updated: 2026-01-13

Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

RecruitingNCT04688736

Institute of Hematology & Blood Diseases Hospital, ChinaAllergic Transfusion Reaction

Start: 2021-01-01End: 2027-06-30Target: 6642Updated: 2025-08-05

Related Papers

Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment

Gut2021-03-1243 citations